MGM Cancer Institute

What MGM Cancer Institute does

MGM Cancer Institute Private Limited is a 150-bed dedicated cancer care hospital located in Aminjikarai, Chennai, operating as part of the MGM Healthcare network. Founded in 2023 per firmographic records (with operational events traceable to 2022), it delivers a fully integrated oncology service portfolio across surgical oncology (including HIPEC for advanced abdominal cancers), medical oncology (chemotherapy, targeted therapy, immunotherapy), radiation oncology, and precision diagnostics supported by AI-enabled imaging (MRI, CT, PET, digital mammography, ultrasound). Specialized offerings include a dedicated Breast Clinic, blood cancer/hematology services, and a Second Opinion Program, complemented by the Swasam patient support group and routine counseling.

The underlying technology stack combines advanced imaging hardware with AI-assisted diagnostic workflows and a digital care platform comprising the MGM Connect mobile app, online video consultation, online treatment enquiry portal, patient portal, and an AI-powered symptom routing assistant. The platform supports structured data, text, audio, and video modalities, with an AI assistant escalating to human support when booking is uncertain. Sub-specialty depth is anchored by named oncology consultants including Dr. M A Raja (Director, Oncology Services), Dr. Sivaram Ganesamoni (HOD, Surgical Oncology), Dr. Veda Padma Priya S (Breast Oncology), Dr. Sivakumar Mahalingam (Surgical Oncology), Dr. N Syed Ismail (Medical Oncology), and Dr. Kirti Katherine Kabeer (Breast Oncoplastic Surgery).

The business model is direct-to-consumer fee-for-service, with pricing determined per case after consultation rather than via published tariffs. Revenue streams span outpatient consultations, surgical and medical oncology procedures, diagnostic and imaging services, and digital health services (video consultations, app-based access). Patient acquisition combines digital content marketing (blog, social media), community events (walkathons, cyclothons), and an international patients program targeting medical tourism. The institute is expanding to a second Chennai location in Alwarpet, indicating a multi-site strategy within the city.

Name

MGM Cancer Institute

Legal name

MGM Cancer Institute Private Limited

Website

https://mgmcancerinstitute.in

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

MGM Cancer Institute is a 150-bed dedicated cancer hospital in Chennai, India, offering surgical, medical, and radiation oncology, AI-enabled diagnostic imaging, and a multidisciplinary care platform to individual cancer patients across India and international medical tourists. The institute is expanding to a second Chennai location in Alwarpet.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Oncology hospital services
• Cancer treatment center
• Surgical oncology
• Radiation therapy
• Precision diagnostics

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Consultation Services: Revenue generated from outpatient consultations, second opinion consultations (both in-person and online/virtual), and follow-up appointments across various oncology specialties
2. Cancer Treatment Services: Comprehensive treatment revenue including surgical oncology procedures, chemotherapy, targeted therapy, immunotherapy, radiation therapy, and HIPEC surgeries
3. Diagnostic and Imaging Services: Revenue from advanced diagnostic tests, imaging services (MRI, CT, PET scans, mammography), laboratory tests, and biopsies
4. Surgical Procedures: Revenue from breast conservation surgery, mastectomy, reconstructive surgeries, and other oncological surgical procedures
5. Digital Health Services: Revenue from online video consultations, AI assistant-guided appointment booking, and digital health platform access (MGM Connect app)

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

MGM Cancer Institute is a 150-bed dedicated cancer care hospital in Chennai, India that provides comprehensive multidisciplinary oncology services spanning surgical oncology, medical oncology (chemotherapy, targeted therapy, immunotherapy), and radiation therapy. The institute operates specialized clinics for breast cancer and blood cancers, offers advanced diagnostics (MRI, CT, PET, mammography) with AI-enabled imaging, and delivers supportive services such as a second opinion program, 24/7 emergency care, and the Swasam patient support group. It complements in-person care with digital platforms including online video consultation and the MGM Connect mobile app.

Product overview

MGM Cancer Institute is a comprehensive 150-bed dedicated cancer care hospital in Chennai, India, offering a fully integrated oncology service portfolio organized around multidisciplinary departments and digital platforms. The core clinical services include Surgical Oncology (with HIPEC surgery), Medical Oncology (spanning chemotherapy, targeted therapy, and immunotherapy), Radiation Oncology, and Precision Diagnostics powered by AI-enabled imaging (MRI, CT, PET scan, digital mammography, ultrasound). Specialized offerings include a dedicated Breast Clinic, Blood Cancer / Hematology Services, and a Second Opinion Program. These clinical services are supported by digital platforms — Patient Portal, Online Video Consultation, Mobile-Based Follow Up — and complemented by patient support services such as the Swasam patient support group, routine counseling sessions, and a health information blog. The institute is expanding with a second location in Alwarpet.

Differentiator

Problem solved

Functional benefit

Products and services

• Surgical Oncology Specialist surgical oncology service providing tumor removal and related surgical procedures (curative, debulking, diagnostic, staging, palliative, and reconstructive) for cancer patients across multiple cancer types.
• Medical Oncology (Chemotherapy, Targeted Therapy, Immunotherapy) Comprehensive medical oncology service delivering chemotherapy, targeted therapy, and immunotherapy treatments for various cancer types, administered by senior consultants in medical oncology.
• Radiation Oncology Radiation therapy service using advanced technology for cancer treatment, delivered as a standalone modality or in combination with surgery and chemotherapy.
• HIPEC Surgery Hyperthermic Intraperitoneal Chemotherapy (HIPEC) surgical procedure that combines cytoreductive surgery with heated chemotherapy for select advanced abdominal cancers.
• Breast Clinic Dedicated breast care center offering risk assessment, triple assessment, mammography, ultrasound and MRI screening, stereotactic and vacuum-assisted biopsies, genetic counseling, breast conservation surgery, mastectomy, oncoplastic surgery, and breast reconstruction for women and men.
• Blood Cancer / Hematology Services Specialized service for diagnosing and treating hematologic malignancies including leukemia, lymphoma, and multiple myeloma, with chemotherapy, targeted therapy, immunotherapy, radiation therapy, and bone marrow or stem cell transplant.
• Second Opinion Program Expert second opinion consultations, available in-person or online, that help patients validate or modify a cancer diagnosis and treatment plan received elsewhere.
• Online Video Consultation Remote medical consultation service delivered via audio call, video call, or chat, enabling patients to consult MGM Cancer Institute oncologists from any location.

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

One partnership is on record.

• TI India (TI Cycles of India)minorStrategic or Co-development Partner · 18 December 2022MGM Cancer Institute partnered with TI India (TI Cycles of India) to organize 'Ride for a Cause – The Cyclathon' on December 18, 2022. The event commenced from TI Cycles of India Ambattur OT and concluded at MGM Cancer Institute, Nelson Manickam Road. The cyclothon promoted healthy lifestyle and cancer awareness among participants.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• HealthCare Global Enterprises (HCG): India's largest dedicated oncology hospital chain, operating cancer centres across multiple cities. Comparable in dedicated oncology focus with broader geographic reach and established referral network.
• Cancer Institute (WIA) Adyar: One of India's oldest dedicated cancer centres, located in Chennai, offering surgical, medical, and radiation oncology. Direct competitor in the same city serving overlapping patient segments.
• Cytecare Cancer Hospitals: Bengaluru-based dedicated cancer hospital offering comprehensive oncology services with a similar 'specialty-only' positioning. Comparable in clinical model and India-market focus.
• Apollo Cancer Centre (Apollo Hospitals): Apollo Hospitals operates dedicated cancer centres including in Chennai, offering comprehensive surgical, medical, and radiation oncology. Strong incumbent brand and multi-specialty hospital network for cross-referrals.
• American Oncology Institute: Network of dedicated cancer hospitals across India, partnering with US-based oncologists. Comparable as a specialty oncology chain targeting tier-1 and tier-2 Indian cities.
• Basavatarakam Indo American Cancer Hospital: Hyderabad-based dedicated cancer hospital and research centre offering comprehensive oncology services. Comparable in dedicated cancer-care model and Indian patient base.

Broad incumbents

• Tata Memorial Hospital: India's premier government-aided cancer hospital in Mumbai, treating the largest volume of cancer cases in the country. Sets clinical benchmarks but is not a direct private competitor due to subsidized pricing.
• Medanta – The Medicity: Multi-specialty tertiary care hospital with a dedicated Cancer Institute offering surgical, medical, and radiation oncology. Competes in advanced oncology cases as part of broader hospital group.
• Fortis Memorial Research Institute: Large multi-specialty private hospital with a significant oncology programme. Competes for the same high-acuity oncology cases but as part of a broader multi-specialty portfolio.
• Max Healthcare (Max Institute of Cancer Care): Large North India-focused hospital chain with a dedicated cancer-care institute offering comprehensive oncology services. Comparable in service breadth but broader multi-specialty positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/MGMHealthcare
• YouTubeyoutube.com/channel/UC7Wpo9j1vqnQm43UcwTm-sw
• Facebookfacebook.com/MGM-Cancer-Institute-100086022656141
• LinkedInlinkedin.com/company/mgm-cancer-institute-india
• Instagraminstagram.com/mgmcancerinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MGM Cancer Institute